Quotables
"We live in a society exquisitely dependent on science and technology, in which hardly anyone knows anything about science and technology."
Carl Sagan
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 6841644 | Biopolymers obtained by solid state irradiation in an unsaturated gaseous atmosphere Disclosed are modified naturally occurring biocompatible biopolymers of plant and animal origin made by subjecting same to ionizing radiation in the presence of a mediating gas, typically acetylene to enable one to selectively enhance and modify one or more of the p... | 01/11/2005 |
| 6750203 | Product derived from milk substantially free of beta casein from non-human mammals and relative use The present invention is related to a product derived from milk, substantially free of beta casein from non-human mammals. The invention is also related to the use of such a product especially in relation to diet, more particularly for early infancy, in the preventi... | 06/15/2004 |
| 6730307 | Anti-cryptosporidium parvum preparations Compositions and methods useful for conferring passive or active immunity to the parasite, C. parvum. A high molecular weight glycoprotein antigen isolated from C. parvum, capable of binding the mAb 3E2, was shown to harbor an epitope critical for trig... | 05/04/2004 |
| 6682737 | Anti-cryptosporidium parvum preparations Compositions and methods useful for conferring passive or active immunity to the parasite, C. parvum. A high molecular weight glycoprotein antigen isolated from C. parvum, capable of binding the mAb 3E2, was shown to harbor an epitope critical for trigger... | 01/27/2004 |
| 6555659 | Process for isolating glycomacropeptide from dairy products with a phenylalanine impurity of 0.5% w/w The present invention is related to a method for the purification of glycomacropeptide (GMP) with an amino acid composition containing no greater that 0.5% (w/w) phenylalanine, comprising the steps of contacting a GMP-containing feedstock with a first ani... | 04/29/2003 |
| 6521591 | Pharmaceutical composition for muscular anabolism A pharmaceutical composition suitable for enhancing muscular anabolism contains, per daily dose, at least 5 mg of anabolic initiators comprising anabolic growth factors, at least 0.12 g of protein equivalents of anabolic substrates and at least 3 g of ana... | 02/18/2003 |
| 6479627 | Aqueous preparation of lactoferrin having improved stability An object of the present invention is to provide an aqueous solution of lactoferrin which can be preserved for a long period of time. The aqueous preparation according to the present invention is an aqueous preparation which is characterized by containing... | 11/12/2002 |
| 6306653 | Detection and treatment of breast disease An isolated chemokine is disclosed. The isolated chemokine is expressed preferentially in breast tissue or can be detected in breast milk. It includes from about 100 to about 132 amino acids, has a deduced molecular weight of from about 10 to about 16 kDa... | 10/23/2001 |
| 6268487 | Purification of biologically active peptides from milk A method of separating a soluble milk component from milk is disclosed. The method involves the use of tangential flow filtration across a membrane to form a retentate and a permeate, combining the permeate with the original milk sample, and repeating thi... | 07/31/2001 |
| 6124258 | Iron-casein complex and process for preparing the same Iron-casein complexes and methods for preparation thereof without iron characteristic astringent taste even by heat sterilization and having high iron supplying effect. The iron-casein complexes can be obtained by mixing three components of solution A con... | 09/26/2000 |
| 6110463 | Anti-Cryptosporidium parvum preparations Compositions and methods useful for conferring passive or active immunity to the parasite, C. parvum. A high molecular weight glycoprotein antigen isolated from C. parvum, capable of binding the mAb 3E2, was shown to harbor an epitope critical for trigger... | 08/29/2000 |
| 5942254 | Phosphorylated recombinant human ଲ-casein expressed in a bacterial system The present invention provides a plasmid containing a promoter sequence, a nucleotide sequence encoding an exogenous protein, and a nucleotide sequence encoding an enzyme capable of modifying the exogenous protein. In a specific embodiment of the inventio... | 08/24/1999 |
| 5919913 | Isolation of lactoferrin from milk The invention provides methods for purification of human lactoferrin from milk, especially milk of nonhuman species, and for separation of human lactoferrin from undesired macromolecular species present in the milk, including separation from nonhuman lact... | 07/06/1999 |
| 5905026 | Method of detecting expression of and isolating the protein encoded by the BRCA1 gene The present disclosure teaches that the proteins encoded by the BRCA1 and BRCA2 genes are found in the milk fat globule membranes from humans and cows. Therefore, BRCA1 and BRCA2 proteins can be isolated from milk produced by lactating animals. The level ... | 05/18/1999 |
| 5863561 | Immune suppressive product An immune suppressive product prepared by injecting an allergen or a mixture of allergens into the body of milk-producing species. Said product being the milk or a polypeptide subfraction of milk obtained from the allergen treated host. The immune suppres... | 01/26/1999 |
| 5861491 | Isolation of lactoferrin from milk The invention provides methods for purification of human lactoferrin from milk, especially milk of nonhuman species, and for separation of human lactoferrin from undesired macromolecular species present in the milk, including separation from nonhuman lact... | 01/19/1999 |
| 5849885 | Isolation of lactoferrin from milk The invention provides methods for purification of human lactoferrin from milk, especially milk of nonhuman species, and for separation of human lactoferrin from undesired macromolecular species present in the milk, including separation from nonhuman lact... | 12/15/1998 |
| 5843705 | Transgenically produced antithrombin III This invention relates to transgenically produced human Antithrombin III (tgATIII). The human ATIII produced by the transgenic process of the present invention has a monosaccharide composition which comprises N-acetylgalactosamine (GaINAc) along with fuco... | 12/01/1998 |
| 5834424 | Use of lactoferrin for therapy of acute of chronic infectious diseases by the intracellular gram-positive pathogens streptococcus pyogenes and staphylococcus aureus Compositions of lactoferrin, ovotransferrin or serotransferrin in apo or iron-saturated form are provided which have bacterial anti-invasive properties against Streptococcus pyogenes and Staphylococcus aureus. Methods of treatment of epithelial calls and ... | 11/10/1998 |
| 5814345 | Immune suppressive product An immune suppressive product prepared by injecting an allergen or a mixture of allergens into the body of milk-producing species. Said product being the milk or a polypeptide subfraction of milk obtained from the allergen treated host. The immune suppres... | 09/29/1998 |
| 5807702 | Method for expressing phosphorylated recombinant human ଲ-casein in a bacterial system The present invention provides a method of producing phophorylated, recombinant human ଲ-casein having 3 to 5 phosphates in a bacterial cell using a single vector containing in tandem both the nucleotide sequence encoding ଲ-casein and a sequenc... | 09/15/1998 |
| 5756687 | Isolation of components of interest from milk Methods of isolating components of interest from a milk sample are described. The methods include a step wherein the solubility of at least a portion of the total milk protein is stabilized in such a manner as to allow isolation of the component of intere... | 05/26/1998 |
| 5756681 | Method for providing contraception A method for preventing pregnancy in a mammal such as a human, by introducing into the reproductive tract of the mammal an effective contraceptive amount of beta-lactoglobulin, either alone or in combination with a pharmaceutically acceptable excipient, c... | 05/26/1998 |
| 5750176 | Transgenic non-human mammal milk comprising 2'-fucosyl-lactose The invention relates to the milk of a transgenic non-human mammal. The milk is characterized in that it contains heterologous components produced as the secondary gene products of a heterologous gene contained in the genome of the transgenic non-human ma... | 05/12/1998 |
| 5750149 | Pharmaceutical and dermocosmetic compositions containing equine colostrum Pharmaceutical and/or dermocosmetic compositions containing equine colostrum, optionally in admixture with milk.... | 05/12/1998 |
| 5721342 | Control of milk secretion A protein which inhibits milk secretion by lactating goats has been isolated from milk by anion exchange of a defined whey fraction, optionally followed by chromatofocussing, and is defined by reference to peaks in which it is found, its molecular weight ... | 02/24/1998 |
| 5710132 | Use of bovine colostral milk as a preparation for the protection of the liver The invention relates to the use of colostral milk or colostral milk preparations from the cow, or fractions containing immunoglobulin prepared therefrom, as a liver protective preparation for the prevention and treatment of liver function disturbances in... | 01/20/1998 |
| 5707968 | Inhibition of attachment of H.influenzae to human cells The attachment of H. influenzae to human cells, such as oropharyngeal cells, may be inhibited by native human ଲ-casein, a recombinant form of human ଲ-casein, and hydrolysates of both. The human ଲ-casein or hydrolysate may be contained in... | 01/13/1998 |
| 5683984 | Enteral tube feeding composition with a native micellar casein protein component An enteral composition of protein, glucides, lipids and minerals, which is suitable for tube feeding, employs native micellar casein as the protein. The composition is prepared by obtaining native micellar casein and combining it with the glucides, lipids... | 11/04/1997 |
| 5681586 | Enzyme-modified soy and soy/casein combination healing compositions A pharmaceutical composition comprising an improved modified protein sol is used for treating and enhancing the healing of arthritis and cutaneous acne. Prior to being modified, a protein is solubilized and neutralized by an alkali solution containing a m... | 10/28/1997 |
| 5667839 | Human recombinant collagen in the milk of transgenic animals Production of human procollagen or collagen in cells which ordinarily do not produce these molecules is effected by constructing expression systems compatible with mammary glands of non-human mammals. For example, expression systems can be microinjected i... | 09/16/1997 |
| 5645834 | Method and product for treating failure of passive transfer and improving milk production in bovine species A product and method of treating failure of passive immunity transfer and for stimulating growth and milk production in cows by administration of proteins purified from bovine colostrum is disclosed. Injecting, either subcutaneously or intravenously, prep... | 07/08/1997 |
| 5643880 | Product for inhibition of attachment of H. influenzae to human cells The attachment of H. influenzae to human cells, such as oropharyngeal cells, may be inhibited by native human ଲ-casein, a recombinant form of human ଲ-casein, and hydrolysates of both. The human ଲ-casein or hydrolysate may be contained in... | 07/01/1997 |
| 5596082 | Process for isolating lactoferrin and lactoperoxidase from milk and milk products, and products obtained by such process A process for isolating the metalloprotein lactoferrin and the enzyme lactoperoxidase from milk and milk products on an industrial scale is disclosed. The process includes the steps of adsorbing these proteins to a cation exchanger by passing milk or the ... | 01/21/1997 |
| 5576300 | Method for inhibition of human rotavirus infection A method of preventing or treating infection by human rotavirus by administering an enteral nutritional product containing either bovine .kappa.-casein or human .kappa.-casein at a concentration greater than that found in human or bovine milk and sufficie... | 11/19/1996 |
| 5561109 | Method for the healing of wounds caused by corneal injury A method for the healing of wounds caused by corneal injury, which includes administering to a mammalian patient in need thereof an effective wound healing amount of lactoferrin, lactoperoxidase or a combination of lactoferrin and lactoperoxidase as activ... | 10/01/1996 |
| 5538952 | Inhibition of infection of mammalian cells by respiratory syncytial virus The infection of mammalian cells by RSV may be inhibited by native human ଲ-casein, a recombinant form of human ଲ-casein, and hydrolysates of both. The human ଲ-casein or hydrolysate may be contained in a liquid enteral nutritional product... | 07/23/1996 |
| 5506209 | Product for inhibition of infection of mammalian cells by respiratory syncytial virus The infection of mammalian cells by RSV may be inhibited by native human ଲ-casein, a recombinant form of human ଲ-casein, and hydrolysates of both. The human ଲ-casein or hydrolysate may be contained in a liquid enteral nutritional product... | 04/09/1996 |
| 5502163 | Control of secretion of milk A protein which inhibits milk secretion by lactating cows and which is present in the second (2A) significant peak when a nominally 10-30 KDa fraction of the whey proteins of the milk is resolved on a "Mono Q" anion exchange column using 10 mM imidazole b... | 03/26/1996 |
| 5496802 | Control of milk secretion A protein which inhibits milk secretion by lactating cows and which is present in the eighth (6B, Figure) significant peak when a nominally 10-30 KDa fraction of the whey proteins of the milk is resolved on a "Mono Q" anion exchange column using 10 mM imi... | 03/05/1996 |
